Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ETON
INBX
Add up to 3 more stocks
ETON
Eton Pharmaceuticals, Inc.
-0.81%
$55.17-0.45Delayed quote: Oct 6, 2026, 11:49 AM EDT
Market Cap
$1.51B
52W Range
$14.27 - $66.37
INBX
Inhibrx Biosciences Inc.
+1.58%
$96.05+1.49Delayed quote: Oct 6, 2026, 11:49 AM EDT
Market Cap
$1.41B
52W Range
$28.16 - $155.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 143.45 | N/A |
| Forward P/E | 50.73 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 32.44 | N/A |
| P/S Ratio | 14.31 | N/A |
| P/FCF Ratio | 102.65 | N/A |
| EV/EBITDA | 72.58 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 57.9% | -91.0% |
| Operating Margin | 0.1% | -10386.5% |
| Net Margin | 12.0% | -10773.5% |
| ROE | 27.2% | N/A |
| ROA | 11.0% | -89.6% |
| ROIC | 20.4% | -99.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.52 | 5.07 |
| Quick Ratio | 1.30 | 5.07 |
| Debt/Equity | 0.62 | N/A |
| Interest Coverage | 0.02 | -11.07 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.